SPECIES VARIABILITY IN THE STEREOSELECTIVE N-OXIDATION OF PARGYLINE

被引:16
|
作者
HADLEY, MR
SVAJDLENKA, E
DAMANI, LA
OLDHAM, HG
TRIBE, J
CAMILLERI, P
HUTT, AJ
机构
[1] UNIV LONDON KINGS COLL,DEPT PHARM,LONDON SW3 6LX,ENGLAND
[2] CHINESE UNIV HONG KONG,FAC MED,DEPT PHARM,SHA TIN,HONG KONG
[3] SMITHKLINE BEECHAM PHARMACEUT,WELWYN GARDEN CIT,HERTS,ENGLAND
关键词
PARGYLINE N-OXIDE; CHIRAL NITROGEN CENTER; FLAVIN-CONTAINING MONOOXYGENASE; CHIRAL STATIONARY PHASE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; CHIRALCEL OD;
D O I
10.1002/chir.530060209
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The monoamine oxidase inhibitor pargyline (N-benzyl-N-methyl-2-propynylamine) is known to undergo extensive in vitro microsomal N-oxidation, thought to be mediated predominantly by the flavin-containing monooxygenase (FMO) enzyme system. Formation of the pargyline N-oxide (PNO) metabolite creates a chiral nitrogen centre and thus asymmetric oxidation is possible. This study describes a reverse-phase high-performance liquid chromatographic (HPLC) method for the quantitation of PNO and a chiral-phase HPLC method for the determination of the enantiomeric ratio of PNO. In vitro microsomal N-oxidation of pargyline was found to be highly steroselective in a number of species, with the (+)-enantiomer being formed preferentially. This metabolic transformation was stereospecific when purified porcine hepatic FMO was used as the enzyme source. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] SPECIES VARIABILITY IN THE STEREOSELECTIVE N-OXIDATION OF N-ETHYL-N-METHYLANILINE
    HADLEY, MR
    OLDHAM, HG
    DAMANI, LA
    HUTT, AJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 : P326 - P326
  • [2] PEROXIDATIVE N-OXIDATION AND N-DEALKYLATION REACTIONS OF PARGYLINE
    WELI, AM
    LINDEKE, B
    XENOBIOTICA, 1986, 16 (03) : 281 - 288
  • [3] STEREOSELECTIVE MICROSOMAL N-OXIDATION OF N-ETHYL-N-METHYLANILINE
    HADLEY, MR
    OLDHAM, HG
    CAMILLERI, P
    MURPHY, J
    HUTT, AJ
    DAMANI, LA
    BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) : 1739 - 1742
  • [4] SPECIES VARIATION IN N-OXIDATION OF CHLORPHENTERMINE
    KOSTER, U
    CALDWELL, J
    SMITH, RL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1974, 2 (05) : 881 - 882
  • [5] SPECIES VARIATIONS IN N-OXIDATION OF CHLORPHENTERMINE
    CALDWELL, J
    KOSTER, U
    SMITH, RL
    WILLIAMS, RT
    BIOCHEMICAL PHARMACOLOGY, 1975, 24 (24) : 2225 - 2232
  • [6] SPECIES-DIFFERENCES IN PULMONARY N-OXIDATION OF CHLORPROMAZINE AND IMIPRAMINE
    OHMIYA, Y
    MEHENDALE, HM
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 732 - 732
  • [7] PULMONARY N-OXIDATION OF NICOTINE AND PYRIDINE IN SEVERAL ANIMAL SPECIES
    OHMIYA, Y
    FUJISAWA, S
    NAKAI, K
    FOLIA PHARMACOLOGICA JAPONICA, 1984, 83 (06) : P59 - P60
  • [8] SPECIES-DIFFERENCES IN PULMONARY N-OXIDATION OF CHLORPROMAZINE AND IMIPRAMINE
    OHMIYA, Y
    MEHENDALE, HM
    PHARMACOLOGY, 1984, 28 (05) : 289 - 295
  • [9] N-DEALKYLATION AND N-OXIDATION OF 2 ALPHA-METHYL-SUBSTITUTED PARGYLINE ANALOGS IN RAT-LIVER MICROSOMES
    WELI, AM
    HOOK, BB
    LINDEKE, B
    ACTA PHARMACEUTICA SUECICA, 1985, 22 (05): : 249 - 264
  • [10] MICROSOMAL N-OXIDATION OF PHENTERMINE
    BECKETT, AH
    BELANGER, PM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (09) : 692 - 699